Wegener's granulomatosis in a patient with a rheumatoid arthritis. 1992

H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
Third Department of Internal Medicine, Hamamatsu University School of Medicine, Japan.

A 38-year-old woman with rheumatoid arthritis who developed Wegener's granulomatosis is described. Wegener's granulomatosis appeared with saddle nose, perforation in her nasal septum, and granuloma in the nasal cavity. Laboratory evaluation showed a positive rheumatoid factor and circulating immune complex. Radiographic examination revealed ankylotic changes in both wrist and elbow joints. Bilateral anosmia and other disease manifestations completely responded to treatment with oral cyclophosphamide and prednisolone.

UI MeSH Term Description Entries
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000857 Olfaction Disorders Impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions. Impaired Olfaction,Olfactory Impairment,Paraosmia,Parosmia,Phantosmia,Smell Disorders,Smell Dysfunction,Cacosmia,Dysosmia,Cacosmias,Dysfunction, Smell,Dysosmias,Impaired Olfactions,Impairment, Olfactory,Olfaction Disorder,Olfaction, Impaired,Olfactions, Impaired,Paraosmias,Parosmias,Phantosmias,Smell Disorder
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012217 Rheumatoid Factor Autoantibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS. Factor, Rheumatoid

Related Publications

H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
February 1994, Likars'ka sprava,
H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
May 1974, The British journal of clinical practice,
H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
September 2003, The Journal of rheumatology,
H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
March 2013, Acta dermato-venereologica,
H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
May 2002, Rheumatology (Oxford, England),
H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
October 1976, Proceedings of the Royal Society of Medicine,
H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
February 1967, American journal of ophthalmology,
H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
December 2008, Cases journal,
H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
October 2012, Rheumatology international,
H Ohashi, and M Itoh, and N Ogawa, and Y Sudo, and S Endo, and T Okugawa, and H Ito, and H Mineta, and M Nozue
August 2012, BMJ case reports,
Copied contents to your clipboard!